{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:10:07Z","timestamp":1791112207521,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.expneurol.2005.08.017","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T14:22:59Z","timestamp":1128435779000},"page":"422-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD"],"prefix":"10.1016","volume":"196","author":[{"given":"F.","family":"Bibbiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kielaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.N.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2005.08.017_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"3","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2005.08.017_bib2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0959-4388(00)00216-6","article-title":"NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity","volume":"3","author":"Ali","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib3","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/WNL.57.10.1829","article-title":"Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models","volume":"10","author":"Bibbiani","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2005.08.017_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-4886(03)00250-4","article-title":"A2A antagonist prevents dopamine agonist-induced motor complications in animal models of PD","volume":"184","author":"Bibbiani","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0149-7634(96)00038-3","article-title":"Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease","volume":"21","author":"Blanchet","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2005.08.017_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/mds.870130507","article-title":"Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys","volume":"13","author":"Blanchet","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2005.08.017_bib7","first-page":"339","article-title":"Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease","volume":"6","author":"Blanchet","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002826-200401000-00008","article-title":"Effect of riluzole on dyskinesia and duration of the on state in Parkinson disease patients: a double-blind, placebo-controlled pilot study","volume":"27","author":"Braz","year":"2004","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2003.07.003","article-title":"Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease","volume":"14","author":"Calon","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2005.08.017_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.parkreldis.2004.02.012","article-title":"Striatal plasticity and extrapyramidal motor dysfunction","volume":"10","author":"Chase","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4 Suppl. 1","key":"10.1016\/j.expneurol.2005.08.017_bib11","first-page":"S122","article-title":"Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications","volume":"47","author":"Chase","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib12","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1471-1931(00)00018-5","article-title":"Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism","volume":"10","author":"Chase","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2005.08.017_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1471-4159.2001.00433.x","article-title":"Tyrosine phosphorylation of the N-methyl-d-aspartate receptor by exogenous and postsynaptic density-associated Src-family kinases","volume":"3","author":"Cheung","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.08.017_bib14","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1523\/JNEUROSCI.0546-04.2004","article-title":"Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand","volume":"24","author":"Chung","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.08.017_bib15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.2004.02257.x","article-title":"Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1\/2 and Akt\/PKB but not JNK in cultured striatal neurones","volume":"88","author":"Crossthwaite","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.08.017_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","article-title":"Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents\u2014Preclinical studies","volume":"21","author":"Danysz","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.expneurol.2005.08.017_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbr.2003.10.009","article-title":"Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias","volume":"152","author":"Delfino","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2005.08.017_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"1","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.expneurol.2005.08.017_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/mol.65.1.121","article-title":"Dopamine D1-dependent trafficking of striatal N-methyl-d-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32","volume":"65","author":"Dunah","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib20","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/00001756-199412000-00045","article-title":"NMDA receptor blockade reverses motor response alterations induced by levodopa","volume":"5","author":"Engber","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2005.08.017_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","article-title":"Rationale for and use of NMDA receptor antagonists in Parkinson's disease","volume":"102","author":"Hallett","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2005.08.017_bib22","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1523\/JNEUROSCI.0799-04.2004","article-title":"Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases","volume":"24","author":"Hayashi","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.08.017_bib23","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1111\/j.0953-816X.2004.03344.x","article-title":"Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary?","volume":"19","author":"Hern\u00e1ndez-Echeagaray","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.08.017_bib24","first-page":"40","article-title":"LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats","volume":"1","author":"Jimenez","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2005.08.017_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1615\/CritRevNeurobiol.v16.i12.140","article-title":"AMPA receptor blockade potentiates the stimulatory effect of l-DOPA on dopamine release in dopamine-deficient corticostriatal slice preparation","volume":"16","author":"Juranyi","year":"2004","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib26","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.54.8.1589","article-title":"AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys","volume":"8","author":"Konitsiotis","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.08.017_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0074-7742(03)54003-X","article-title":"Signaling molecules and receptor transduction cascades that regulate NMDA receptor-mediated synaptic transmission","volume":"54","author":"Kotecha","year":"2003","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0006-8993(02)03757-5","article-title":"Receptor subtype-specific modulation by dopamine of glutamatergic responses in striatal medium spiny neurons","volume":"2","author":"Lin","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.08.017_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/(SICI)1098-2396(199708)26:4<381::AID-SYN6>3.0.CO;2-2","article-title":"Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease","volume":"4","author":"Loschmann","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2005.08.017_bib31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/1531-8257(200009)15:5<873::AID-MDS1017>3.0.CO;2-I","article-title":"Beneficial effects of amantadine on l-dopa-induced dyskinesias in Parkinson's disease","volume":"5","author":"Luginger","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2005.08.017_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(96)00693-2","article-title":"MK801 prevents levodopa-induced motor response alterations in parkinsonian rats","volume":"736","author":"Marin","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.08.017_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1098-2396(20000615)36:4<267::AID-SYN3>3.0.CO;2-Y","article-title":"Non-NMDA receptor mediated mechanisms are involved in levodopa-induced motor response alterations in parkinsonian rats","volume":"36","author":"Marin","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2005.08.017_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/syn.1097","article-title":"LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats","volume":"1","author":"Marin","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2005.08.017_bib35","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(99)00120-8","article-title":"Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease","volume":"353","author":"Merims","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2005.08.017_bib36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1471-4159.2002.00876.x","article-title":"Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A","volume":"4","author":"Nishi","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.08.017_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00726-001-0118-2","article-title":"Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease","volume":"23","author":"Oh","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.expneurol.2005.08.017_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0006-8993(99)01121-X","article-title":"Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits","volume":"2","author":"Oh","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.08.017_bib39","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410390505","article-title":"Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys","volume":"5","author":"Papa","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.08.017_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(95)00924-3","article-title":"Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade","volume":"701","author":"Papa","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.08.017_bib41","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.expneurol.2005.08.017_bib42","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1212\/WNL.51.2_Suppl_2.S25","article-title":"Classification of fluctuations in patients with Parkinson's disease","volume":"51","author":"Quinn","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.08.017_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1040-7952(99)80005-6","article-title":"Regulation of ligand-gated ion channels by protein phosphorylation","volume":"33","author":"Swope","year":"1999","journal-title":"Adv. Second Messenger Phosphoprot. Res."},{"key":"10.1016\/j.expneurol.2005.08.017_bib44","first-page":"141","article-title":"Duration of amantadine benefit on dyskinesia of severe Parkinson's disease","volume":"75","author":"Thomas","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2005.08.017_bib45","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.50.5.1323","article-title":"Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease","volume":"50","author":"Verhagen Metman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.08.017_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1212\/WNL.51.1.203","article-title":"Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease","volume":"51","author":"Verhagen Metman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2005.08.017_bib47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuropharm.2004.03.011","article-title":"NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemiparkinsonian rats","volume":"47","author":"Wessell","year":"2004","journal-title":"Neuropharmacology"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605003171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605003171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:32:29Z","timestamp":1758000749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488605003171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0014488605003171"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2005.08.017","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2005.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}